| __timestamp | MiMedx Group, Inc. | Takeda Pharmaceutical Company Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 105558000 | 1256834000000 |
| Thursday, January 1, 2015 | 167094000 | 1271973000000 |
| Friday, January 1, 2016 | 212608000 | 1173296000000 |
| Sunday, January 1, 2017 | 285920000 | 1274610000000 |
| Monday, January 1, 2018 | 322725000 | 1437534000000 |
| Tuesday, January 1, 2019 | 256174000 | 2201424000000 |
| Wednesday, January 1, 2020 | 208904000 | 2203504000000 |
| Friday, January 1, 2021 | 215332000 | 2462160000000 |
| Saturday, January 1, 2022 | 219525000 | 2783406000000 |
| Sunday, January 1, 2023 | 266843000 | 2832257000000 |
| Monday, January 1, 2024 | 2832257000000 |
Infusing magic into the data realm
In the competitive landscape of pharmaceuticals, Takeda Pharmaceutical Company Limited and MiMedx Group, Inc. present a fascinating study in contrasts. Over the past decade, Takeda has consistently demonstrated robust growth, with its gross profit soaring by approximately 125% from 2014 to 2023. This Japanese giant's financial prowess is evident, peaking at an impressive $2.83 trillion in 2023.
Conversely, MiMedx Group, Inc., a smaller player in the industry, has shown a more modest trajectory. Despite a 153% increase in gross profit from 2014 to 2023, its figures remain a fraction of Takeda's, highlighting the disparity in scale and market reach. Notably, MiMedx's data for 2024 is missing, leaving room for speculation on its future performance.
These insights underscore the dynamic nature of the pharmaceutical sector, where strategic positioning and market size play pivotal roles in financial outcomes.
Gross Profit Analysis: Comparing Eli Lilly and Company and MiMedx Group, Inc.
Gross Profit Trends Compared: Pfizer Inc. vs Takeda Pharmaceutical Company Limited
Gross Profit Trends Compared: Gilead Sciences, Inc. vs MiMedx Group, Inc.
Who Generates Higher Gross Profit? Takeda Pharmaceutical Company Limited or Teva Pharmaceutical Industries Limited
Takeda Pharmaceutical Company Limited and Bio-Techne Corporation: A Detailed Gross Profit Analysis
Gross Profit Analysis: Comparing Takeda Pharmaceutical Company Limited and BioMarin Pharmaceutical Inc.
Gross Profit Trends Compared: Takeda Pharmaceutical Company Limited vs Taro Pharmaceutical Industries Ltd.
Revenue Insights: Takeda Pharmaceutical Company Limited and MiMedx Group, Inc. Performance Compared
Gross Profit Trends Compared: Takeda Pharmaceutical Company Limited vs Evotec SE
Gross Profit Trends Compared: Jazz Pharmaceuticals plc vs MiMedx Group, Inc.
Gross Profit Analysis: Comparing HUTCHMED (China) Limited and MiMedx Group, Inc.
Who Generates Higher Gross Profit? Evotec SE or MiMedx Group, Inc.